Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drug Safety
Published in: Drug Safety 10/2007

01-10-2007 | Abstracts

Poster Presentations

Authors: J. Woron, T. Kaczmarzyk, R. Korbut, A. Arab

Published in: Drug Safety | Issue 10/2007

Login to get access

Excerpt

Background: The selective serotonin reuptake inhibitors (SSRIs) are involved in many drug-drug interactions because of their pharmacokinetic properties. Many of SSRIs are metabolised by cytochrome P450 isoenzymes and they can inhibit the activity of isoenzymes that metabolise other concomitantly used drugs in polytherapy. …
Metadata
Title
Poster Presentations
Authors
J. Woron
T. Kaczmarzyk
R. Korbut
A. Arab
Publication date
01-10-2007
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 10/2007
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/00002018-200730100-00073

Other articles of this Issue 10/2007

Drug Safety 10/2007 Go to the issue

Abstracts

Poster Presentations

Abstracts

Poster Presentations

Abstracts

Poster Presentations

Abstracts

Poster Presentations

Abstracts

Poster Presentations

Abstracts

Poster Presentations